Search Results - Marie‐Sara Agier

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Rituximab-induced serum sickness is more frequent in autoimmune diseases as compared to hematological malignancies: A French nationwide study

    Rituximab-induced serum sickness is more frequent in autoimmune diseases as compared to hematological malignancies: A French nationwide study by Guillaume Bayer, Marie‐Sara Agier, Bertrand Lioger, Marion Lepelley, M. Zénut, Mary-Christine Lanoue, F. Maillot, A.‐P. Jonville‐Béra

    Published 2019
    Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Rituximab and mycophenolate mofetil combination in patients with interstitial lung disease (EVER-ILD): a double-blind, randomised, placebo-controlled trial

    Rituximab and mycophenolate mofetil combination in patients with interstitial lung disease (EVER-ILD): a double-blind, randomised, placebo-controlled trial by Julie Mankikian, Agnès Caille, Martine Reynaud‐Gaubert, Marie‐Sara Agier, Julien Bermudez, Philippe Bonniaud, Raphaël Borie, Pierre‐Yves Brillet, J. Cadranel, Isabelle Court‐Fortune, Bruno Crestani, Marie‐Pierre Debray, E. Gomez, Anne Gondouin, Sandrine Hirschi-Santelmo, Dominique Israëł-Biet, S. Jouneau, Karine Juvin, Julie Léger, M. Kerjouan, Charles‐Hugo Marquette, Jean‐Marc Naccache, Hilario Nunès, Laurent Plantier, Grégoire Prévôt, Sébastien Quétant, Julie Traclet, V. Valentin, Y. Uzunhan, Lidwine Wémeau-Stervinou, Théodora Bejan‐Angoulvant, Vincent Cottin, S. Marchand‐Adam

    Published 2023
    Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: